ESC 365 - Selexipag dosing and titration in the first 500 patients enrolled in SPHERE (SelexiPag: tHe UsErs dRug rEgistry)

ESC Premium Access

Selexipag dosing and titration in the first 500 patients enrolled in SPHERE (SelexiPag: tHe UsErs dRug rEgistry)

Session: Poster Session 4 - Pulmonary arterial hypertension - Treatments

Topic: Pulmonary Hypertension

Speaker: Professor V. McLaughlin (Ann Arbor, US)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Vallerie McLaughlin

University of Michigan, Ann Arbor (United States of America)

5 presentations

0 follower

10 more presentations in this session

Efficacy of the novel thromboxane receptor antagonist NTP42 alone, or in combination with Sildenafil, in the sugen/hypoxia-induced model of pulmonary arterial hypertension

Speaker: Professor T. Kinsella (Dublin, IE)

Effects of inhaled nitrite in addition to sildenafil in thalassemia patients with pulmonary hypertension

Speaker: Doctor T. Sasiprapha (Bangkok, TH)

Electroanatomical mapping of right atrium in patients with pulmonary hypertension

Speaker: Doctor Z. Fingrova (Prague, CZ)

Patient characteristics and treatment patterns in the multicentre, retrospective chart review of first-time Opsumit (macitentan) users in the United States (OrPHeUS)

Speaker: Professor V. McLaughlin (Ann Arbor, US)

Prognostic implications of early detection and treatment of left main coronary artery compression by a pulmonary artery among pulmonary arterial hypertension patients

Speaker: Doctor J. Nuche (Madrid, ES)

Access the full session

Poster Session 4 - Pulmonary arterial hypertension - Treatments

Speakers: Professor V. McLaughlin, Professor T. Kinsella, Doctor T. Sasiprapha, Doctor Z. Fingrova, Professor V. McLaughlin...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources